LifeMD (LFMDP) Cash from Financing Activities (2012 - 2025)

LifeMD has reported Cash from Financing Activities for 14 years, with the latest figure at -$788562.0 in Q4 2025.

• For the quarter ending Q4 2025, Cash from Financing Activities rose 15.65% year-over-year to -$788562.0; the trailing twelve-month figure through Dec 2025 stood at -$13.4 million (down 225.52% YoY), and the FY2025 full-year result was -$13.4 million, down 225.52% from the prior year.
• Cash from Financing Activities for Q4 2025 stood at -$788562.0, up from -$8.7 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $39.3 million in Q4 2021, with the low at -$8.7 million in Q3 2025.
• Historically, Cash from Financing Activities has averaged $4.0 million across 5 years, with a median of -$781312.5 in 2022.
• Annual changes were most pronounced in 2023 — Cash from Financing Activities jumped 1649.16% — and 2025, when it slumped 558.85%.
• LifeMD's Cash from Financing Activities stood at $39.3 million in 2021, then plunged by 95.26% to $1.9 million in 2022, then jumped by 671.21% to $14.4 million in 2023, then sank by 106.51% to -$934903.0 in 2024, then gained by 15.65% to -$788562.0 in 2025.
• The last three Cash from Financing Activities figures came in at -$788562.0 (Q4 2025), -$8.7 million (Q3 2025), and -$3.1 million (Q2 2025), per Business Quant data.